gefitinib has been researched along with fk 866 in 1 studies
| Studies (gefitinib) | Trials (gefitinib) | Recent Studies (post-2010) (gefitinib) | Studies (fk 866) | Trials (fk 866) | Recent Studies (post-2010) (fk 866) |
|---|---|---|---|---|---|
| 5,231 | 566 | 2,919 | 188 | 3 | 154 |
| Protein | Taxonomy | gefitinib (IC50) | fk 866 (IC50) |
|---|---|---|---|
| Cytochrome P450 1A2 | Homo sapiens (human) | 0.001 | |
| Cytochrome P450 3A4 | Homo sapiens (human) | 0.001 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 0.001 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.001 | |
| Nicotinamide phosphoribosyltransferase | Homo sapiens (human) | 0.0095 | |
| Nicotinamide phosphoribosyltransferase | Mus musculus (house mouse) | 0.0038 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Jiang, S; Li, Z; Liao, C; Liu, Y; Ni, Y; Qiang, L; Qiu, Y; Tu, Z; Wang, D; Yao, Y; Zhang, K; Zhang, W | 1 |
1 other study(ies) available for gefitinib and fk 866
| Article | Year |
|---|---|
Dual nicotinamide phosphoribosyltransferase and epidermal growth factor receptor inhibitors for the treatment of cancer.
Topics: Animals; Antineoplastic Agents; Cell Proliferation; Cell Survival; Cytokines; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Mice; Mice, Inbred BALB C; Mice, Nude; Molecular Docking Simulation; Molecular Structure; Neoplasms, Experimental; Nicotinamide Phosphoribosyltransferase; Structure-Activity Relationship; Tumor Cells, Cultured | 2021 |